To: J. Nelson who wrote (3868 ) 5/6/1999 6:41:00 PM From: J. Nelson Respond to of 4650
*****ADOT 05-06-99 NEWS***** From : Business Wire Advanced Optics Electronics Inc. ALBUQUERQUE, N.M.--(BUSINESS WIRE)--May 6, 1999--Advanced Optics Electronics Inc. (OTC BB:ADOT) announced Thursday that BioModa Inc. has made the following announcement: Albuquerque, N.M.--April 30, 1999--BioModa Inc. announced today the election, at its annual shareholders meeting, the appointment of Leslie Robins as a director of BioModa Inc. Robins is the executive vice president of Advanced Optics Electronics Inc. In addition, Robins brings to the BioModa board his experience and knowledge gained from many years in the management and financing of development stage companies. "His expertise will be a valuable addition to our board," stated Ari Ma'ayan, BioModa's president. BioModa Inc. is a development stage company focused on the early diagnosis and treatment of lung cancer. Advanced Optics Electronics Inc. has recently filed its first quarter 1999 10Q with the SEC. This reflects progress in its program to bring the flat panel display to the marketplace. The company has initiated discussions to acquire a substantial minority interest in a privately held early-stage fiberoptics switching company located in the Albuquerque area. If concluded, this minority acquisition would create the nucleus of a separate fiberoptic division for Advanced Optics Electronics Inc. Advanced Optics Electronics Inc. (OTC BB:ADOT) is a developer of patented electronic display technology. The initial product is being marketed to users and owners of Outdoor Billboards as a total replacement for static billboards. This is coupled with the ability to change images from a remote location. In addition to the core business of ADOT, the company has identified and placed a strategic and high potential return investment in BioModa Inc. BioModa Inc. is a company that holds patents and patents pending domestically and internationally in the technology for early detection of Lung Cancer. ADOT currently holds approximately 22 percent of BioModa Inc. This news release contains forward-looking statements with respect to the results of operations and business of the company that involves risk and uncertainties. The company's actual future results could materially differ from those discussed. Risks and uncertainties of the company will be detailed from time to time in the company's periodic reports to be filed with the Securities and Exchange Commission. Contact Advanced Optics Electronics Inc. at 505/797-7878 or visit their Web site at www.adot.org. Contact: Advanced Optics Electronics Inc. 505/797-7878 (www.adot.org)